1 / 17

Essential Thrombocytosis

Essential Thrombocytosis. Presence of a chronic nonreactive thrombocythemic state that is not accounted for by one of the other chronic myeloproliferative disorders [chronic myelogenous leukemia (CML), polycythemia vera (PV), primary myelofibrosis (PMF)]. . Epidemiology. 2.5 new cases/100,000 popu

lela
Télécharger la présentation

Essential Thrombocytosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Essential Thrombocytosis AM Report Bridger Clarke 12/10/2007

    2. Essential Thrombocytosis Presence of a chronic nonreactive thrombocythemic state that is not accounted for by one of the other chronic myeloproliferative disorders [chronic myelogenous leukemia (CML), polycythemia vera (PV), primary myelofibrosis (PMF)].

    3. Epidemiology 2.5 new cases/100,000 population per year Approximately 6,000 people are diagnosed each year in the US. Female to male ratio of approximately 2:1 Median age at diagnosis is 60 years

More Related